These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 7011111)
1. Cutaneous responses to tests with influenza vaccines. Buttar K; Chernesky M; Dolovich J Ann Allergy; 1981 Apr; 46(4):183-8. PubMed ID: 7011111 [TBL] [Abstract][Full Text] [Related]
2. Influenza immunization in children and young adults: clinical reactions and total and IgM antibody responses after immunization with whole-virus or split-product influenza vaccines. Bernstein DI; Zahradnik JM; DeAngelis CJ; Cherry JD Am J Dis Child; 1982 Jun; 136(6):513-7. PubMed ID: 7046421 [TBL] [Abstract][Full Text] [Related]
3. Clinical experience with inactivated, virosomal influenza vaccine. de Bruijn IA; Nauta J; Cramer WC; Gerez L; Palache AM Vaccine; 2005 Jul; 23 Suppl 1():S39-49. PubMed ID: 16005120 [TBL] [Abstract][Full Text] [Related]
4. Randomized, double-blind comparative trial of subunit and virosomal influenza vaccines for immunocompromised patients. Evison J; Farese S; Seitz M; Uehlinger DE; Furrer H; Mühlemann K Clin Infect Dis; 2009 May; 48(10):1402-12. PubMed ID: 19361304 [TBL] [Abstract][Full Text] [Related]
5. Immunogenicity, safety, and cross-reactivity of an inactivated, adjuvanted, prototype pandemic influenza (H5N1) vaccine: a phase II, double-blind, randomized trial. Wu J; Fang HH; Chen JT; Zhou JC; Feng ZJ; Li CG; Qiu YZ; Liu Y; Lu M; Liu LY; Dong SS; Gao Q; Zhang XM; Wang N; Yin WD; Dong XP Clin Infect Dis; 2009 Apr; 48(8):1087-95. PubMed ID: 19281330 [TBL] [Abstract][Full Text] [Related]
6. Stimulation of peripheral blood lymphocytes of children by influenza vaccine. Buttar K; Perets A; Chernesky M; Dolovich J Ann Allergy; 1980 May; 44(5):263-6. PubMed ID: 7377638 [TBL] [Abstract][Full Text] [Related]
8. Long-lasting immunogenicity of a virosomal vaccine in older children and young adults with type I diabetes mellitus. Zuccotti GV; Scaramuzza A; Riboni S; Mameli C; Pariani E; Tanzi E; Zanetti A; Radaelli G Vaccine; 2009 Aug; 27(39):5357-62. PubMed ID: 19607951 [TBL] [Abstract][Full Text] [Related]
9. Pandemic preparedness: lessons learnt from H2N2 and H9N2 candidate vaccines. Hehme N; Engelmann H; Künzel W; Neumeier E; Sänger R Med Microbiol Immunol; 2002 Dec; 191(3-4):203-8. PubMed ID: 12458361 [TBL] [Abstract][Full Text] [Related]
10. Trivalent inactivated subunit influenza vaccine Influvac: 25-Year experience of safety and immunogenicity. Giezeman KM; Nauta J; de Bruijn IA; Palache AM Vaccine; 2009 Apr; 27(18):2414-7. PubMed ID: 19368782 [TBL] [Abstract][Full Text] [Related]
11. Reactions following administration of influenza vaccine alone or with pneumococcal vaccine to the elderly. Honkanen PO; Keistinen T; Kivelä SL Arch Intern Med; 1996 Jan; 156(2):205-8. PubMed ID: 8546555 [TBL] [Abstract][Full Text] [Related]
12. Antiviral drugs in influenza: an adjunct to vaccination in some situations. Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114 [TBL] [Abstract][Full Text] [Related]
13. Dermal testing of vaccines for children at high risk of allergies. Sugai K; Shiga A; Okada K; Iwata T; Ogura H; Maekawa K; Yokota S Vaccine; 2007 Apr; 25(17):3454-63. PubMed ID: 17276555 [TBL] [Abstract][Full Text] [Related]
14. Clinical and epidemiological evaluation of a live, cold-adapted influenza vaccine for 3-14-year-olds. Rudenko LG; Lonskaya NI; Klimov AI; Vasilieva RI; Ramirez A Bull World Health Organ; 1996; 74(1):77-84. PubMed ID: 8653819 [TBL] [Abstract][Full Text] [Related]
15. Safety and immunogenicity of CPG 7909 injection as an adjuvant to Fluarix influenza vaccine. Cooper CL; Davis HL; Morris ML; Efler SM; Krieg AM; Li Y; Laframboise C; Al Adhami MJ; Khaliq Y; Seguin I; Cameron DW Vaccine; 2004 Aug; 22(23-24):3136-43. PubMed ID: 15297066 [TBL] [Abstract][Full Text] [Related]
16. Antibody induction by virosomal, MF59-adjuvanted, or conventional influenza vaccines in the elderly. de Bruijn I; Meyer I; Gerez L; Nauta J; Giezeman K; Palache B Vaccine; 2007 Dec; 26(1):119-27. PubMed ID: 18063446 [TBL] [Abstract][Full Text] [Related]
17. [Comparative study on safety and immunogenicity between influenza subunit vaccine and split vaccine]. Dong PM; Li YQ; Zheng TZ; Jia YP; Li F; Han TW; Qiao RX; Zhang BH Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Jul; 24(7):570-3. PubMed ID: 12975010 [TBL] [Abstract][Full Text] [Related]
18. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming? Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948 [TBL] [Abstract][Full Text] [Related]
19. Mucosal (SIgA) and serum (IgG) immunologic responses in young adults following intranasal administration of one or two doses of inactivated, trivalent anti-influenza vaccine. Greenbaum E; Engelhard D; Levy R; Schlezinger M; Morag A; Zakay-Rones Z Vaccine; 2004 Jun; 22(20):2566-77. PubMed ID: 15193382 [TBL] [Abstract][Full Text] [Related]
20. Immune response to influenza vaccination in children and adults with asthma: effect of corticosteroid therapy. Hanania NA; Sockrider M; Castro M; Holbrook JT; Tonascia J; Wise R; Atmar RL; J Allergy Clin Immunol; 2004 Apr; 113(4):717-24. PubMed ID: 15100679 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]